These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22798667)

  • 1. Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo.
    Stromnes IM; Fowler C; Casamina CC; Georgopolos CM; McAfee MS; Schmitt TM; Tan X; Kim TD; Choi I; Blattman JN; Greenberg PD
    J Immunol; 2012 Aug; 189(4):1812-25. PubMed ID: 22798667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of SHP-1 Expands the Repertoire of Antitumor T Cells Available to Respond to Immune Checkpoint Blockade.
    Snook JP; Soedel AJ; Ekiz HA; O'Connell RM; Williams MA
    Cancer Immunol Res; 2020 Apr; 8(4):506-517. PubMed ID: 32075800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHP-1 in T cells limits the production of CD8 effector cells without impacting the formation of long-lived central memory cells.
    Fowler CC; Pao LI; Blattman JN; Greenberg PD
    J Immunol; 2010 Sep; 185(6):3256-67. PubMed ID: 20696858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purity of transferred CD8(+) T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1.
    Watson HA; Dolton G; Ohme J; Ladell K; Vigar M; Wehenkel S; Hindley J; Mohammed RN; Miners K; Luckwell RA; Price DA; Matthews RJ; Ager A
    Immunol Cell Biol; 2016 Sep; 94(8):802-8. PubMed ID: 27430370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHP-1 phosphatase activity counteracts increased T cell receptor affinity.
    Hebeisen M; Baitsch L; Presotto D; Baumgaertner P; Romero P; Michielin O; Speiser DE; Rufer N
    J Clin Invest; 2013 Mar; 123(3):1044-56. PubMed ID: 23391724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc.
    Chandran SS; Paria BC; Srivastava AK; Rothermel LD; Stephens DJ; Kammula US
    Cancer Res; 2015 Aug; 75(16):3216-26. PubMed ID: 26100671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of PTPN22 improves effector and memory CD8+ T cell responses to tumors.
    Brownlie RJ; Wright D; Zamoyska R; Salmond RJ
    JCI Insight; 2019 Jul; 5(16):. PubMed ID: 31335326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
    Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
    Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of programmed death-1 pathway rescues the effector function of tumor-infiltrating T cells and enhances the antitumor efficacy of lentivector immunization.
    Zhou Q; Xiao H; Liu Y; Peng Y; Hong Y; Yagita H; Chandler P; Munn DH; Mellor A; Fu N; He Y
    J Immunol; 2010 Nov; 185(9):5082-92. PubMed ID: 20926790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1.
    Taylor A; Akdis M; Joss A; Akkoç T; Wenig R; Colonna M; Daigle I; Flory E; Blaser K; Akdis CA
    J Allergy Clin Immunol; 2007 Jul; 120(1):76-83. PubMed ID: 17531298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative autoregulation of Src homology region 2-domain-containing phosphatase-1 in rat basophilic leukemia-2H3 cells.
    Ozawa T; Nakata K; Mizuno K; Yakura H
    Int Immunol; 2007 Sep; 19(9):1049-61. PubMed ID: 17675340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OX40 and Bcl-xL promote the persistence of CD8 T cells to recall tumor-associated antigen.
    Song A; Tang X; Harms KM; Croft M
    J Immunol; 2005 Sep; 175(6):3534-41. PubMed ID: 16148096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia.
    Oda SK; Daman AW; Garcia NM; Wagener F; Schmitt TM; Tan X; Chapuis AG; Greenberg PD
    Blood; 2017 Nov; 130(22):2410-2419. PubMed ID: 29042364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.
    Stromnes IM; Blattman JN; Tan X; Jeevanjee S; Gu H; Greenberg PD
    J Clin Invest; 2010 Oct; 120(10):3722-34. PubMed ID: 20890046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
    Nakamura K; Brauweiler A; Cambier JC
    J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy.
    Wei J; Long L; Zheng W; Dhungana Y; Lim SA; Guy C; Wang Y; Wang YD; Qian C; Xu B; Kc A; Saravia J; Huang H; Yu J; Doench JG; Geiger TL; Chi H
    Nature; 2019 Dec; 576(7787):471-476. PubMed ID: 31827283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy.
    Mihalyo MA; Doody AD; McAleer JP; Nowak EC; Long M; Yang Y; Adler AJ
    J Immunol; 2004 May; 172(9):5338-45. PubMed ID: 15100273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fate and function of anti-CD3/CD28-activated T cells following adoptive transfer: IL-2 promotes development of anti-tumor memory T cells in vivo.
    Hughes DP; Baskar D; Urban FF; Friedman MS; Braun TM; McDonagh KT
    Cytotherapy; 2005; 7(5):396-407. PubMed ID: 16236629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 production is positively regulated by two distinct Src homology domain 2-containing tyrosine phosphatase-1 (SHP-1)-dependent CCAAT/enhancer-binding protein β and NF-κB pathways and an SHP-1-independent NF-κB pathway in lipopolysaccharide-stimulated bone marrow-derived macrophages.
    Rego D; Kumar A; Nilchi L; Wright K; Huang S; Kozlowski M
    J Immunol; 2011 May; 186(9):5443-56. PubMed ID: 21422245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.